ESSA Pharma
Stock Forecast, Prediction & Price Target
ESSA Pharma (EPIX) stock Price Target by analysts
$11.33
Potential upside: 493.36%
ESSA Pharma price prediction
What is ESSA Pharma stock analysts` prediction?
ESSA Pharma stock forecast: Based on 3 Wall Street analysts` predicted price targets for ESSA Pharma in the last 3 months, the avarage price target is $11.33, with a high forecast of $NaN. The average price target represents a 493.36% change from the last price of $1.91.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
ESSA Pharma stock Price Target by analysts
Full breakdown of analysts given ESSA Pharma price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Joseph Catanzaro Piper Sandler | 0% 0/1 | 10 months ago | $2 4.71% upside | $1.63 | StreetInsider | Previous targets (0) |
Leland Gershell Oppenheimer | 0% 0/1 | 12 months ago | $17 790.05% upside | $6.85 | StreetInsider | Previous targets (0) |
Tyler Van Buren Piper Sandler | 0% 0/1 | 12 months ago | $15 685.34% upside | $6.85 | StreetInsider | Previous targets (0) |
ESSA Pharma Financial Estimates
ESSA Pharma Revenue Estimates
ESSA Pharma EBITDA Estimates
ESSA Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $4.45M Low: $4.45M High: $4.45M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $30.02M Low: $30.02M High: $30.02M avg. 0% |
Net Income
% change YoY
| $-35.10M N/A | $-26.58M 24.27% | $0 100% | Avg: $-53.40M Low: $-92.66M High: $-27.35M avg. 0% | Avg: $-75.39M Low: $-124.89M High: $-29.55M avg. -41.16% | Avg: $-87.29M Low: $-87.29M High: $-87.29M avg. -15.78% | Avg: $-75.39M Low: $-75.39M High: $-75.39M avg. 13.63% |
EBITDA
% change YoY
| $-35.22M N/A | $-26.45M 24.88% | $0 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.8 N/A | -$0.6 25.00% | -$0.64 -6.66% | Avg: -$1.02 Low: -$2.1 High: -$0.62 avg. -59.97% | Avg: -$1.36 Low: -$2.83 High: -$0.67 avg. -32.86% | Avg: -$1.98 Low: -$1.98 High: -$1.98 avg. -45.55% | Avg: -$1.71 Low: -$1.71 High: -$1.71 avg. 13.63% |
Operating Expenses
% change YoY
| $36.96M N/A | $32.13M -13.05% | $21.20M -34.00% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is ESSA Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -10.82% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -92.66M, average is -53.40M and high is -27.35M.
What is ESSA Pharma stock revenue growth forecast?
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is ESSA Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -31.18% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.1, average is -$1.02 and high is $-0.62.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering ESSA Pharma stock. The most successful analyst is Joseph Catanzaro.